InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Explore the detailed record of transactions filed by Myles David C., Directeur du Développement. Officer active across 1 company, notably Olema Pharmaceuticals, Inc.. Cumulatively, 2 disclosures have been published. Breakdown: 0 buy · 2 sells. Total volume traded: €182k. History available since 10 December 2021. The latest transaction was disclosed on 10 December 2021 (Cession). Regulator: SEC (Form 4). All data is openly available.
Declarations2 total
10,000 shares@ US$10.300.0077% mcap100.0% of flowCommon StockSEC:0001415889-21-005860
10,000 shares@ US$10.300.0077% mcap50.0% of flowCommon StockSEC:0001415889-21-005860:0
2 of 2 declarations
About Myles David C.
David C. Myles is the Chief Development Officer at Olema Pharmaceuticals, Inc. He is responsible for product development strategy and innovation. His role is crucial for the growth and success of the firm in the pharmaceutical sector.
